0.0470
-0.0015
(-3.09%)
May 17 - Close
OTCMKTS
data delayed by 15 mins -
Disclaimer
Currency in USD
| Range | 0.05 - 0.05 |
| 52 week | 0.03 - 0.12 |
| Open | 0.05 |
| Vol / Avg. | 1.15M/2.90M |
| Mkt cap | 33.58M |
| P/E | - |
| Div/yield | - |
| EPS | -0.04 |
| Shares | 714.54M |
| Beta | 4.47 |
| Inst. own | 0% |
Key stats and ratios
| Q3 (Sep '12) | 2011 | |
| Net profit margin | -112203.20% | -11314.84% |
| Operating margin | -111804.30% | -11314.06% |
| EBITD margin | - | -4323.34% |
| Return on average assets | -466.63% | -10600.70% |
| Return on average equity | - | - |
| Employees | 2 | - |
| Carbon Disclosure Rating | - | - |
Address
Suite B #254, 6946 North Academy Blvd
COLORADO SPRINGS, CO 80918
United States - Map
+1-972-4505990 (Phone)
COLORADO SPRINGS, CO 80918
United States - Map
+1-972-4505990 (Phone)
Website links
External links
Discussion Group - Google Finance
Advertisement
Description
Cannabis Science, Inc., is a development-stage company. The Company is engaged in the creation of cannabis-based medicines, both with and without psychoactive properties, to treats disease and the symptoms of disease, as well as for general health maintenance. The Company is engaged in medical marijuana research and development. On February 9, 2012, the Company acquired GGECO University, Inc. (GGECO). On March 21, 2012, the Company acquired Cannabis Consulting Inc. (CCI Group).
Officers and directors
| Robert J. Melamede Ph.D. | President, Chief Executive Officer, Interim Chief Financial Officer, Director | |
| Moe Afaneh | Chief Operating Officer | |
| Chad S. Johnson Esq. | General Corporate Counsel, Director | |
| Richard Cowan | Secretary |